{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T13:18:22Z","timestamp":1782998302167,"version":"3.54.5"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2019,5,12]],"date-time":"2019-05-12T00:00:00Z","timestamp":1557619200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100005635","name":"Funda\u00e7\u00e3o Calouste Gulbenkian","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005635","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Serum antibodies that bind to the surface of neurons or glia are associated with a wide range of rare but treatable CNS diseases. In many, if not most instances, the serum levels are higher than CSF levels yet most of the reported attempts to reproduce the human disease in mice have used infusion of antibodies into the mouse cerebral ventricle(s) or intrathecal space. We used the intraperitoneal route and injected purified plasma IgG from either a CASPR2-antibody-positive patient (n = 10 mice) or healthy individual (n = 9 mice) daily for 8 days. Lipopolysaccharide was injected intraperitoneally on Day 3 to cause a temporary breach in the blood brain barrier. A wide range of baseline behaviours, including tests of locomotion, coordination, memory, anxiety and social interactions, were established before the injections and tested from Day 5 until Day 11. At termination, brain tissue was analysed for human IgG, CASPR2 and c-fos expression, lymphocyte infiltration, and neuronal, astrocytic and microglial markers. Mice exposed to CASPR2-IgG, compared with control-IgG injected mice, displayed reduced working memory during the continuous spontaneous alternation test with trends towards reduced short-term and long-term memories. In the open field tests, activities were not different from controls, but in the reciprocal social interaction test, CASPR2-IgG injected mice showed longer latency to start interacting, associated with more freezing behaviour and reduced non-social activities of rearing and grooming. At termination, neuropathology showed more IgG deposited in the brains of CASPR2-IgG injected mice, but a trend towards increased CASPR2 expression; these results were mirrored in short-term in vitro experiments where CASPR2-IgG binding to hippocampal neurons and to CASPR2-transfected HEK cells led to some internalization of the IgG, but with a trend towards higher surface CASPR2 expression. Despite these limited results, in the CASPR2-IgG injected mouse brains there was increased c-fos expression in the piriform-entorhinal cortex and hypothalamus, and a modest loss of Purkinje cells. There was also increased microglia density, morphological changes in both microglia and astrocytes and raised complement C3 expression on astrocytes, all consistent with glial activation. Patients with CASPR2 antibodies can present with a range of clinical features reflecting central, autonomic and peripheral dysfunction. Although the behavioural changes in mice were limited to social interactions and mild working-memory defects, the neuropathological features indicate potentially widespread effects of the antibodies on different brain regions.<\/jats:p>","DOI":"10.1093\/brain\/awz119","type":"journal-article","created":{"date-parts":[[2019,4,23]],"date-time":"2019-04-23T15:13:22Z","timestamp":1556032402000},"page":"2000-2012","source":"Crossref","is-referenced-by-count":51,"title":["Behaviour and neuropathology in mice injected with human contactin-associated protein 2 antibodies"],"prefix":"10.1093","volume":"142","author":[{"given":"Maria Pia","family":"Giannoccaro","sequence":"first","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"},{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Menassa","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"},{"name":"Biological Sciences, University of Southampton, Southampton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Coutinho","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Prota","sequence":"additional","affiliation":[{"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Lang","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Isabel","family":"Leite","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cerundolo","sequence":"additional","affiliation":[{"name":"MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Liguori","sequence":"additional","affiliation":[{"name":"Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy"},{"name":"IRCSS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[{"name":"Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,5,11]]},"reference":[{"key":"2019080110302680600_awz119-B1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J Neuroinflammation"},{"key":"2019080110302680600_awz119-B2","doi-asserted-by":"crossref","first-page":"9746","DOI":"10.1523\/JNEUROSCI.17-24-09746.1997","article-title":"Effects of sleep on wake- induced c-fos expression","volume":"17","author":"Basheer","year":"1997","journal-title":"J Neurosci"},{"key":"2019080110302680600_awz119-B3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jnnp-2011-301506","article-title":"Contactin-associated protein-2 antibodies in non-paraneoplastic cerebellar ataxia","volume":"83","author":"Becker","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019080110302680600_awz119-B4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","article-title":"Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome","volume":"24","author":"Bien","year":"2017","journal-title":"Eur J Neurol"},{"key":"2019080110302680600_awz119-B5","doi-asserted-by":"crossref","first-page":"263ra158","DOI":"10.1126\/scitranslmed.3009759","article-title":"The gut microbiota influences blood-brain barrier permeability in mice","volume":"6","author":"Braniste","year":"2014","journal-title":"Sci Transl Med"},{"key":"2019080110302680600_awz119-B6","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/mp.2016.165","article-title":"Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice","volume":"21","author":"Brimberg","year":"2016","journal-title":"Mol Psychiatry"},{"key":"2019080110302680600_awz119-B7","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","article-title":"Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome","volume":"70","author":"Chang","year":"2013","journal-title":"JAMA Neurol"},{"key":"2019080110302680600_awz119-B8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/jnnp-2016-315251","article-title":"CASPR2 autoantibodies are raised during pregnancy in mothers of children with mental retardation and disorders of psychological development but not autism","volume":"88","author":"Coutinho","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2019080110302680600_awz119-B9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00401-017-1751-5","article-title":"Persistent microglial activation and synaptic loss with behavioral abnormalities in mouse offspring exposed to CASPR2-antibodies in utero","volume":"134","author":"Coutinho","year":"2017","journal-title":"Acta Neuropathol"},{"key":"2019080110302680600_awz119-B10","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"key":"2019080110302680600_awz119-B11","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1073\/pnas.80.24.7636","article-title":"Passive transfer of Lambert-Eaton myasthenic syndrome with IgG from man to mouse depletes the presynaptic membrane active zones","volume":"80","author":"Fukunaga","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019080110302680600_awz119-B12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.mcn.2015.11.012","article-title":"Expression of Cntnap2 (Caspr2) in multiple levels of sensory systems","volume":"70","author":"Gordon","year":"2016","journal-title":"Mol Cell Neurosci"},{"key":"2019080110302680600_awz119-B13","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awq213","article-title":"Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin- associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia","volume":"133","author":"Irani","year":"2010","journal-title":"Brain"},{"key":"2019080110302680600_awz119-B14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.brainresprot.2004.04.002","article-title":"Grooming analysis algorithm for neurobehavioural stress research","volume":"13","author":"Kalueff","year":"2004","journal-title":"Brain Res Protoc"},{"key":"2019080110302680600_awz119-B15","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1212\/NXI.0000000000000075","article-title":"Complement-associated neuronal loss in a patient with CASPR2 antibody-associated encephalitis","volume":"2","author":"Ko\u00fcrtvelyessy","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflammation"},{"key":"2019080110302680600_awz119-B16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"2019080110302680600_awz119-B17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0149-7634(01)00041-0","article-title":"The neurobiological basis of spontaneous alternation","volume":"26","author":"Lalonde","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"key":"2019080110302680600_awz119-B18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1523\/JNEUROSCI.2117-15.2016","article-title":"Astrocyte-microglia cross talk through complement activation modulates amyloid pathology in mouse models of Alzheimer\u2019s disease","volume":"36","author":"Lian","year":"2016","journal-title":"J Neurosci"},{"key":"2019080110302680600_awz119-B19","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactinve astroctes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"2019080110302680600_awz119-B20","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1093\/brain\/124.12.2417","article-title":"Morvan\u2019s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels","volume":"124","author":"Liguori","year":"2001","journal-title":"Brain"},{"key":"2019080110302680600_awz119-B21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.physbeh.2013.05.003","article-title":"Assessment of social interaction and anxiety-like behavior in senescence-accelerated-prone and -resistant mice","volume":"118","author":"Meeker","year":"2013","journal-title":"Physiol Behav"},{"key":"2019080110302680600_awz119-B22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","article-title":"Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia","volume":"83","author":"Patterson","year":"2018","journal-title":"Ann Neurol"},{"key":"2019080110302680600_awz119-B23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0165-5728(96)00144-0","article-title":"Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis","volume":"71","author":"Piddlesden","year":"1996","journal-title":"J Neuroimmunol"},{"key":"2019080110302680600_awz119-B24","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/brain\/awu310","article-title":"Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice","volume":"138","author":"Planagum\u00e0","year":"2015","journal-title":"Brain"},{"key":"2019080110302680600_awz119-B25","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/S0140-6736(05)66376-3","article-title":"Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin","volume":"365","author":"Sommer","year":"2005","journal-title":"Lancet"},{"key":"2019080110302680600_awz119-B26","first-page":"453","article-title":"Morvan syndrome with Caspr2 antibodies","volume":"372","author":"Sundal","year":"2017","journal-title":"Clinical and autopsy report. J Neurol Sci"},{"key":"2019080110302680600_awz119-B27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hipo.10037","article-title":"The entorhinal cortex of the mouse: organization of the projection to the hippocampal formation","volume":"13","author":"van Groen","year":"2003","journal-title":"Hippocampus"},{"key":"2019080110302680600_awz119-B28","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","article-title":"The clinical spectrum of Caspr2 antibody\u2014associated","volume":"87","author":"Van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"2019080110302680600_awz119-B29","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp Neurol"},{"key":"2019080110302680600_awz119-B30","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1093\/brain\/awv257","article-title":"Epileptogenic effects of NMDAR antibodies in a passive transfer mouse model","volume":"138","author":"Wright","year":"2015","journal-title":"Brain"},{"key":"2019080110302680600_awz119-B31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2014.12.008","article-title":"Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of A\u03b2PP metabolites in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"264","author":"Xu","year":"2015","journal-title":"Exp Neurol"},{"key":"2019080110302680600_awz119-B32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026991","article-title":"Genetic ablation of PLAG6 in mice leads to cerebellar atrophy characterized by purkinje cell loss and glial cell activation","volume":"6","author":"Zhao","year":"2011","journal-title":"PLoS One"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awz119\/28600386\/awz119.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/142\/7\/2000\/29028515\/awz119.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T18:43:26Z","timestamp":1569091406000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/142\/7\/2000\/5488145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,11]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2019,5,11]]},"published-print":{"date-parts":[[2019,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awz119","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2019,5,11]]}}}